Pediatric singulair side effects

Pediatric sur Amazon - Pediatric en stock.

Singulair is indicated in the treatment of asthma as add-on therapy in those 6 months to 5 year old patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “as-needed” short acting β-agonists provide inadequate clinical control of asthma.

Singulair paediatric montelukast - NetDoctor

Singulair (montelukast) is a leukotriene (loo-koe-TRY-een) inhibitor.

<b>Singulair</b> <b>Side</b> <b>Effects</b> in Detail -

Side Effects For Singulair

Applies to montelukast: oral packet, oral tablet, oral tablet chewable As well as its needed effects, montelukast (the active ingredient contained in Singulair) may cause unwanted side effects that require medical attention.

Singulair Side Effects in Detail -

Singulair paediatric is used for children aged six months and over whose asthma is not fully controlled by using regular inhaled corticosteroids and short-acting beta agonist relievers such as salbutamol. Singulair paediatric may also be used as an alternative to low-dose inhaled corticosteroids for children aged 2 to 14 years who have mild persistant asthma but can't use inhaled corticosteroids.

Pediatric singulair side effects:

Rating: 95 / 100

Overall: 87 Rates